bioSyntagma

Biology, Sincle Cell Expression, Heterogeneity, Cancer, Omics research, Biomarkers, Next Generation Sequencing, Big Data, Data Visualization

[bioSyntagma @bioSyntagma]

Our tests are already servicing many local health departments, businesses, and assisted living facilities, as well as out of state groups.
If your organization is in need of tests, please contact us. #covid19 #startup

[bioSyntagma @bioSyntagma]

Whether in the face of cancer or #covid19, our mission has always been to save lives – to give people more time with their families. At the end of March, our company temporarily pivoted from cancer diagnostics to #covid19testing in the midst of the global pandemic.

[bioSyntagma @bioSyntagma]

We are experts in molecular testing and have used our knowledge in partnership with two Arizona labs to develop a high throughput test with 24-hour turnaround times.

[bioSyntagma @bioSyntagma]

CEO David Richardson prepares to unveil a novel method for spatially mapping tumors and stratifying cancer patients. Look for us at #AMPath19

[TakaraBioUSA @TakaraBioUSA]

Come hear @bioSyntagma’s David Richardson discuss #tumor microenvironment spatial analysis from FFPE samples utilizing the SmartChip™ PCR system during our #AMPath19 workshop on Wed., Nov. 6 at 10 am. Learn more: https://t.co/Ck16FuD274 #AMP19 #TakaraBio #ThatsGoodScience #qPCR

[bioSyntagma @bioSyntagma]

bioSyntagma awarded $735k from the @NSF to complete product development of its Molecular Fingerprint (mPrint) platform. A spatial, multi-omic tool to enable precision medicine. #lifescience #PrecisionMedicine #startuplife @techreview @TechCrunch

[bioSyntagma @bioSyntagma]

bioSyntagma developing a 'google maps' that allows researchers and scientists to construct 3D single cell genomic networks. RT Buzz of BIO!

[AZ Bioscience News @FlinnBio]

AZ #Bioscience News: @TGen leads CTE study; @CORE_Institute gains $50M; @bioSyntagma receives federal grant https://t.co/tLAzTZxnrW

[bioSyntagma @bioSyntagma]

Grateful for the FLINN foundation for their early support. Could not have got here without them. https://t.co/QPJ6llcew0

[AZ Bioscience News @FlinnBio]

Our Entrepreneurship Program participant @bioSyntagma gets $214K from @NSFSBIR to develop microfluidic chip tech https://t.co/ghniGVyJCG

[bioSyntagma @bioSyntagma]

Venture Devils startup, bioSyntagma, wins NSF grant https://t.co/ekq16HMD0p

[bioSyntagma @bioSyntagma]

bioSyntagma has created a tool to answer the big questions in science that can lead to cures for cancer, diabetes, and alzheimers. #moonshot

[Jason H. Moore, PhD @moorejh]

Dear Every #Cancer Patient I Ever Cared For - I'm Sorry https://t.co/JpsbAoYjV5 #health #healthcare #oncology HT @deansittig

[bioSyntagma @bioSyntagma]

Before and after photos showing cell ablation in-situe localization of Tcell (green) & APC's (red). NA sent for expression analysis.

[bioSyntagma @bioSyntagma]

Before and after photos showing cell ablation in-situe localization of Tcell (green) & APC's (red). NA sent for expression analysis.